Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,828,643
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
8,785,097
-
Shares change
-
+60,495
-
Total reported value, excl. options
-
$67,961,804
-
Value change
-
+$530,664
-
Number of buys
-
21
-
Number of sells
-
-20
-
Price
-
$7.32
Significant Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q1 2021
52 filings reported holding ETON - Eton Pharmaceuticals, Inc. - Common Stock as of Q1 2021.
Eton Pharmaceuticals, Inc. - Common Stock (ETON) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,785,097 shares
of 26,828,643 outstanding shares and own 32.75% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (4,040,000 shares), BlackRock Inc. (1,086,266 shares), AWM Investment Company, Inc. (898,878 shares), VANGUARD GROUP INC (710,859 shares), STATE STREET CORP (266,295 shares), GEODE CAPITAL MANAGEMENT, LLC (265,545 shares), NORTHERN TRUST CORP (177,958 shares), Sio Capital Management, LLC (162,659 shares), TWO SIGMA INVESTMENTS, LP (139,989 shares), and Westside Investment Management, Inc. (86,525 shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.